Pan American Crohn's and Colitis Organization (PANCCO) and the Interamerican Society of Endoscopy (SIED) consensus on endoscopy in inflammatory bowel disease
DOI:
https://doi.org/10.47892/rgp.2024.442.1713Keywords:
Inflammatory bowel diseases, Crohn disease, Colitis, ulcerative, Endoscopy, Diagnosis, TherapyAbstract
Introduction: Endoscopy plays a fundamental role in inflammatory bowel disease (IBD), and becomes essential in diagnosis, treatment monitoring, and detection and management of complications. Materials and methods: The Pan American Crohn's and Colitis Organization (PANCCO) and the Inter-American Society of Endoscopy (SIED) appointed 22 Latin American experts in IBD to develop a consensus study using the modified Delphi method, based on the best available evidence. A working group of 22 members from 9 countries identified 15 topics and formulated 98 statements, who participated in 2 rounds of voting. It was defined as agreement of ≥80% of experts for each statement. Results: After the voting of all the statements, 8 statements were obtained that did not reach 80% consensus among the participants, so the questions were reconsidered in the Coordinating Committee of the consensus with the participation of the expert reviewers of these questions and 7 final statements were voted again by all the experts in a second round and 1 was eliminated with consensus. After two rounds of voting, the experts reached consensus with literature review with the best available evidence, the most important issues were developed with scientific evidence supporting each of the statements around the topic of endoscopy in IBD. Conclusions: Consensus statements were developed and based on the best available evidence about endoscopy in inflammatory bowel disease.
Downloads
Metrics
References
Peyrin-Biroulet L, Sandborn W, Sands BE, Reinisch W, Bemelman W, Bryant R V, et al. Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target. Am J Gastroenterol. 2015;110(9):1324-38.
Turner D, Ricciuto A, Lewis A, D’Amico F, Dhaliwal J, Griffiths AM, et al. STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD. Gastroenterology. 2021;160(5):1570-83.
Christensen B, Rubin DT. Understanding Endoscopic Disease Activity in IBD: How to Incorporate It into Practice. Curr Gastroenterol Rep. 2016;18(1):1-11.
Leighton JA, Shen B, Baron TH, Adler DG, Davila R, Egan J V, et al. ASGE guideline: Endoscopy in the diagnosis and treatment of inflammatory bowel disease. Gastrointest Endosc. 2006;63(4):558-65.
Annese V, Daperno M, Rutter MD, Amiot A, Bossuyt P, East J, et al. European evidence based consensus for endoscopy in inflammatory bowel disease. J Crohns Colitis. 2013;7(12):982-1018. doi: 10.1016/j.crohns.2013.09.016.
Mosli MH, Feagan BG, Sandborn WJ, D’Haens G, Behling C, Kaplan K, et al. Histologic evaluation of ulcerative colitis: A systematic review of disease activity indices. Inflamm Bowel Dis. 2014;20(3):564-75.
Neurath MF, Travis SPL. Mucosal healing in inflammatory bowel diseases: A systematic review. Gut. 2012;61(11):1619-35.
Lee JS, Kim ES, Moon W. Chronological review of endoscopic indices in inflammatory bowel disease. Clin Endosc. 2019;52(2):129-36.
Lamb CA, Kennedy NA, Raine T, Hendy PA, Smith PJ, Limdi JK, et al. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut. 2019;68:s1-106.
Vuitton L, Marteau P, Sandborn WJ, Levesque BG, Feagan B, Vermeire S, et al. IOIBD technical review on endoscopic indices for Crohn’s disease clinical trials. Gut. 2016;65(9):1447-55.
Daperno M, Comberlato M, Bossa F, Armuzzi A, Biancone L, Bonanomi AG, et al. Training Programs on Endoscopic Scoring Systems for Inflammatory Bowel Disease Lead to a Significant Increase in Interobserver Agreement Among Community Gastroenterologists. J Crohns Colitis. 2017;11(5):556-61.
Daperno M, Comberlato M, Bossa F, Biancone L, Bonanomi AG. Inter-observer agreement in endoscopic scoring systems: preliminary report of an ongoing study from the Italian Group for Inflammatory Bowel Disease (IG-IBD). 2014;1-2.
Daperno M, D’Haens G, Van Assche G, Baert F, Bulois P, Maunoury V, et al. Development and validation of a new, simplified endoscopic activity score for Crohn’s disease: The SES-CD. Gastrointest Endosc. 2004;60(4):505-12.
Sipponen T, Nuutinen H, Turunen U, Färkkilä M. Endoscopic evaluation of Crohn’s disease activity : comparison of the CDEIS and the SES-CD. Inflamm Bowel Dis. 2010;16(12):2131-6.
Moskovitz DN, Daperno M VAG. Defining and validating cutoffs for the Simple Endocopic Score for Crohn’s Disease. Gastroenterology. 2007;132(S1097):1-13.
Akiyama S, Yamada A, Ollech JE, Komaki Y, Komaki F, Pekow J, et al. Predictability of simple endoscopic score for Crohn’s disease for postoperative outcomes in Crohn’s disease. J Gastroenterol Hepatol. 2021;36(10):2785-93.
Bitoun A, Blanchi A, Contou JF, Delchier JC, Florent C, Gendre JP, et al. Development and validation of an endoscopic index of the severity for Crohn’s disease: A prospective multicentre study. Gut. 1989;30(7):983-9.
Rutgeerts P, Sandborn WJ, Feagan BG, Reinisch W, Olson A, Johanns J, et al. Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis. N Engl J Med. 2005;353(23):2462-76.
Ungaro RC, Yzet C, Bossuyt P, Baert FJ, Vanasek T, D’Haens GR, et al. Deep Remission at 1 Year Prevents Progression of Early Crohn’s Disease. Gastroenterology. 2020;159(1):139-47.
Limdi JK, Picco M, Farraye FA. A review of endoscopic scoring systems and their importance in a treat-to-target approach in inflammatory bowel disease (with videos). Gastrointest Endosc. 2020;91(4):733-45.
Rutgeerts P, Geboes K, Vantrappen G, Beyls J, Kerremans R, Hiele M. Predictability of the postoperative course of Crohn’s disease. Gastroenterology. 1990;99(4):956-63.
Rutgeerts P, Geboes K, Vantrappen G, Kerremans R, Coenegrachts JL, Coremans G. Natural history of recurrent Crohns disease at the ileocolonic anastomosis after curative surgery. Gut. 1984;25(6):665-72.
Kim KO. Endoscopic activity in inflammatory bowel disease: clinical significance and application in practice. Clin Endosc. 2022;55(4):480-8.
Ollech JE, Aharoni-Golan M, Weisshof R, Normatov I, Sapp AR, Kalakonda A, et al. Differential risk of disease progression between isolated anastomotic ulcers and mild ileal recurrence after ileocolonic resection in patients with Crohn’s disease. Gastrointest Endosc. 2019;90(2):269-75.
Rivière P, Pekow J, Hammoudi N, Wils P, De Cruz P, Wang CP, et al. Comparison of the Risk of Crohn’s Disease Postoperative Recurrence between Modified Rutgeerts Score i2a and i2b Categories: An Individual Patient Data Meta-analysis. J Crohn’s Colitis. 2023;17(2):269-76.
Schroeder KW, Tremaine WJ, Ilstrup DM. Coated Oral 5-Aminosalicylic Acid Therapy for Mildly to Moderately Active Ulcerative Colitis. N Engl J Med. 1987;317(26):1625-9.
Walsh AJ, Ghosh A, Brain AO, Buchel O, Burger D, Thomas S, et al. Comparing disease activity indices in ulcerative colitis. J Crohn’s Colitis. 2014;8(4):318-25.
Lobatón T, Bessissow T, De Hertogh G, Lemmens B, Maedler C, Van Assche G, et al. The Modified Mayo Endoscopic Score (MMES): A New Index for the Assessment of Extension and Severity of Endoscopic Activity in Ulcerative Colitis Patients. J Crohns Colitis. 2015;9(10):846-52.
Travis SPL, Schnell D, Krzeski P, Abreu MT, Altman DG, Colombel JF, et al. Reliability and initial validation of the ulcerative colitis endoscopic index of severity. Gastroenterology. 2013;145(5):987-95.
Corte C, Fernandopulle N, Catuneanu AM ari., Burger D, Cesarini M, White L, et al. Association between the ulcerative colitis endoscopic index of severity (UCEIS) and outcomes in acute severe ulcerative colitis. J Crohns Colitis. 2015;9(5):376-81.
Xie T, Zhang T, Ding C, Dai X, Li Y, Guo Z, et al. Ulcerative Colitis Endoscopic Index of Severity (UCEIS) versus Mayo Endoscopic Score (MES) in guiding the need for colectomy in patients with acute severe colitis. Gastroenterol Rep. 2018;6(1):38-44.
Cotter J, Dias De Castro F, Magalhães J, João Moreira M, Rosa B. Validation of the Lewis score for the evaluation of small bowel Crohn’s disease activity. Endoscopy. 2014;7(2):330-5.
Niv Y, Ilani S, Levi Z, Hershkowitz M, Niv E, Fireman Z, et al. Validation of the Capsule Endoscopy Crohns Disease Activity Index (CECDAI or Niv score): A multicenter prospective study. Endoscopy. 2012;44(1):21-6.
Rosa B, Pinho R, de Ferro SM, Almeida N, Cotter J, Saraiva MM. Endoscopic Scores for Evaluation of Crohn’s Disease Activity at Small Bowel Capsule Endoscopy: General Principles and Current Applications. GE Port J Gastroenterol. 2016;23(1):36-41.
Yablecovitch D, Lahat A, Neuman S, Levhar N, Avidan B, Ben-Horin S, et al. The Lewis score or the capsule endoscopy Crohn’s disease activity index: Which one is better for the assessment of small bowel inflammation in established Crohn’s disease? Therap Adv Gastroenterol. 2018;11:27-8.
Omori T, Kambayashi H, Murasugi S, Ito A, Yonezawa M, Nakamura S, et al. Comparison of Lewis Score and Capsule Endoscopy Crohn’s Disease Activity Index in Patients with Crohn’s Disease. Dig Dis Sci. 2020;65(4):1180-8.
Sandborn WJ, Tremaine WJ, Batts KP, Pemberton JH, Phillips SF. Pouchitis After Ileal Pouch-Anal Anastomosis: A Pouchitis Disease Activity Index. Mayo Clin Proc. 1994;69(5):409-15.
Shen B, Achkar JP, Connor JT, Ormsby AH, Remzi FH, Bevins CL, et al. Modified pouchitis disease activity index: A simplified approach to the diagnosis of pouchitis. Dis Colon Rectum. 2003;46(6):748-53.
Samaan MA, Shen B, Mosli MH, Zou G, Sandborn WJ, Shackelton LM, et al. Reliability among central readers in the evaluation of endoscopic disease activity in pouchitis. Gastrointest Endosc. 2018;88(2):360-369.e2.
Travis S, Silverberg MS, Danese S, Gionchetti P, Löwenberg M, Jairath V, et al. Vedolizumab for the Treatment of Chronic Pouchitis. N Engl J Med. 2023;388(13):1191-200.
Sedano R, Nguyen TM, Almradi A, Rieder F, Parker CE, Shackelton LM, et al. Disease Activity Indices for Pouchitis: A Systematic Review. Inflamm Bowel Dis. 2022;28(4):622-38.
Sedano R, Ma C, Hogan M, Silverberg MS, Zou G, D’Haens GR, et al. P268 Development and validation of a novel composite index for the assessment of endoscopic and histologic disease activity in pouchitis: The Atlantic pouchitis index. J Crohn’s Colitis. 2023;17(Supplement_1):i416-7.
Ardalan ZS, Con D, Chandran S, Digby-Bell J, Gibson D, Pham A, et al. The Reliability and Accuracy of Endoscopic Items and Scores Used in the Assessment of the Ileoanal Pouch and Cuff. J Crohn’s Colitis. 2022;16(1):18-26.
Barnes EL, Long MD, Raffals L, Isaacs K, Stidham RW, Herfarth HH, et al. Development of the Endoscopic Pouch Score for Assessment of Inflammatory Conditions of the Pouch. Clin Gastroenterol Hepatol. 2023;21(6):1663-1666.e3.
Osterman MT. Mucosal healing in inflammatory bowel disease. J Clin Gastroenterol. 2013;47(3):212-21.
Zenlea T, Yee EU, Rosenberg L, Boyle M, Nanda KS, Wolf JL, et al. Histology grade is independently associated with relapse risk in patients with ulcerative colitis in clinical remission: A prospective study. Am J Gastroenterol. 2016;111(5):685-90.
Geboes K, Riddell R, Öst A, Jensfelt B, Persson T, Löfberg R. A reproducible grading scale for histological assessment of inflammation in ulcerative colitis. Gut. 2000;47(3):404-9.
Mosli MH, Feagan BG, Zou G, Sandborn WJ, D’Haens G, Khanna R, et al. Development and validation of a histological index for UC. Gut. 2017;66(1):50-8.
Marchal-Bressenot A, Salleron J, Boulagnon-Rombi C, Bastien C, Cahn V, Cadiot G, et al. Development and validation of the Nancy histological index for UC. Gut. 2017;66(1):43-9.
Bitton A, Peppercorn MA, Antonioli DA, Niles JL, Shah S, Bousvaros A, et al. Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis. Gastroenterology. 2001;120(1):13-20.
Bessissow T, Lemmens B, Ferrante M, Bisschops R, Van Steen K, Geboes K, et al. Prognostic value of serologic and histologic markers on clinical relapse in ulcerative colitis patients with mucosal healing. Am J Gastroenterol. 2012;107(11):1684-92.
Kevans D, Kirsch R, Dargavel C, Kabakchiev B, Riddell R, Silverberg MS. Histological markers of clinical relapse in endoscopically quiescent ulcerative colitis. Inflamm Bowel Dis. 2020;26(11):1722-9.
Vashist NM, Samaan M, Mosli MH, Parker CE, Macdonald JK, Nelson SA, et al. Endoscopic scoring indices for evaluation of disease activity in ulcerative colitis. Cochrane Database Syst Rev. 2018;1(1):CD011450.
Mojtahed A, Khanna R, Sandborn WJ, D’Haens GR, Feagan BG, Shackelton LM, et al. Assessment of histologic disease activity in crohn’s disease: A systematic review. Inflamm Bowel Dis. 2014;20(11):2092-103.
Geboes K, Rutgeerts P, Opdenakker G, Olson A, Patel K, Wagner CL, et al. Endoscopic and histologic evidence of persistent mucosal healing and correlation with clinical improvement following sustained infliximab treatment for Crohn’s disease. Curr Med Res Opin. 2005;21(11):1741-54.
Naini B V, Cortina G. A histopathologic scoring system as a tool for standardized reporting of chronic (ileo)colitis and independent risk assessment for inflammatory bowel disease. Hum Pathol. 2012;43(12):2187-96.
Gong W, Guo K, Zheng T, Fang M, Xie H, Li W, et al. Correlation between endoscopic and histological validated scoring indices in Crohn’s disease. Dig Liver Dis. 2019;51(6):812-7.
Christensen B. Histologic Healing in Inflammatory Bowel Disease. Gastroenterol Hepatol. 2022;18(8):466-8.
Magro F, Doherty G, Peyrin-Biroulet L, Svrcek M, Borralho P, Walsh A, et al. ECCO position paper: Harmonization of the approach to ulcerative colitis histopathology. J Crohn’s Colitis. 2020;14(11):1503-11.
Neri B, Mossa M, Scucchi L, Sena G, Palmieri G, Biancone L. Histological scores in inflammatory bowel disease. J Dig Dis. 2021;22(1):9-22.
Fumery M, Chatelain D. Histological Scores in Inflammatory Bowel Disease: A New Kid in the Block. J Crohn’s Colitis. 2021;15(10):1603-4.
Mejía-Rivas M, Yamamoto-Furusho J, Remes-Troche JM, Uscanga L. Crohn’s disease of the upper digestive tract. A rare presentation of an uncommon disease in Mexico. Rev Gastroenterol Mex. 2009;74(2):19666292.
Hummel TZ, Ten Kate FJW, Reitsma JB, Benninga MA, Kindermann A. Additional value of upper GI tract endoscopy in the diagnostic assessment of childhood IBD. J Pediatr Gastroenterol Nutr. 2012;54(6):753-7.
Sainz E, Zabana Y, Miguel I, Fernández-Clotet A, Beltrán B, Núñez L, et al. Clinical features, therapeutic requirements and evolution of patients with Crohn’s disease and upper gastrointestinal involvement (CROHNEX study). Aliment Pharmacol Ther. 2021;54(8):1041-51.
Jouin H, Baumann R, Abbas A, Duclos B, Weill-Bousson M, Weill JP. [Esophagogastroduodenal localizations of Crohn’s disease are frequent]. Gastroenterol Clin Biol. 1986;10(8–9):549-53.
Naranjo-Rodríguez A, Solórzano-Peck G, López-Rubio F, Calañas-Continente A, Gálvez-Calderón C, González-Galilea A, et al. Isolated oesophageal involvement of Crohn’s disease. Eur J Gastroenterol Hepatol. 2003;15(10):1123-6.
Kang MS, Park D Il, Park JH, Kim HJ, Cho YK, Sohn C Il, et al. Bamboo joint-like appearance of stomach in Korean patients with Crohn’s disease. Korean J Gastroenterol. 2006;48(6):395-400.
Fujiya M, Sakatani A, Dokoshi T, Tanaka K, Ando K, Ueno N, et al. A bamboo joint-like appearance is a characteristic finding in the upper gastrointestinal tract of Crohn’s disease patients: A case-control study. Med (United States). 2015;94(37):1-2.
Sakuraba A, Iwao Y, Matsuoka K, Naganuma M, Ogata H, Kanai T, et al. Endoscopic and pathologic changes of the upper gastrointestinal tract in Crohn’s disease. Biomed Res Int. 2014;2014:5-6.
AbdullGaffar B, Quraishi H. Histopathologic Manifestations of Crohn Disease in Duodenal Endoscopy Biopsy: The Value of Different Patterns of Involvement of Brunner Glands. Int J Surg Pathol. 2021;29(7):710-5.
Fan YC, Steele D, Kochar B, Arsene D, Long MD, Dellon ES. Increased Prevalence of Esophageal Eosinophilia in Patients with Inflammatory Bowel Disease. Inflamm Intest Dis. 2019;3(4):180-6.
Graca-Pakulska K, Błogowski W, Zawada I, Deskur A, Dąbkowski K, Urasińska E, et al. Endoscopic findings in the upper gastrointestinal tract in patients with Crohn’s disease are common, highly specific, and associated with chronic gastritis. Sci Rep. 2023;13(1):1-2.
Maaser C, Sturm A, Vavricka SR, Kucharzik T, Fiorino G, Annese V, et al. ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications. J Crohn’s Colitis. 2019;13(2):144-64.
Kopylov U, Yung DE, Engel T, Vijayan S, Har-Noy O, Katz L, et al. Diagnostic yield of capsule endoscopy versus magnetic resonance enterography and small bowel contrast ultrasound in the evaluation of small bowel Crohn’s disease: Systematic review and meta-analysis. Dig Liver Dis. 2017;49(8):854-63.
Lazarev M, Huang C, Bitton A, Cho JH, Duerr RH, McGovern DP, et al. Relationship between proximal Crohn’s disease location and disease behavior and surgery: A cross-sectional study of the IBD genetics consortium. Am J Gastroenterol. 2013;108(1):106-12.
Flamant M, Trang C, Maillard O, Sacher-Huvelin S, Rhun M Le, Galmiche JP, et al. The prevalence and outcome of jejunal lesions visualized by small bowel capsule endoscopy in Crohn’s disease. Inflamm Bowel Dis. 2013;19(7):1390-6.
Greener T, Klang E, Yablecovitch D, Lahat A, Neuman S, Levhar N, et al. The impact of magnetic resonance enterography and capsule endoscopy on the re-classification of disease in patients with known Crohn’s Disease: A prospective Israeli IBD research nucleus (IIRN) study. J Crohn’s Colitis. 2016;10(5):525-31.
Mitselos I V, Katsanos KH, Tsianos E V, Eliakim R, Christodoulou DK. Clinical use of patency capsule: A comprehensive review of the literature. Inflamm Bowel Dis. 2018;24(11):2339-47.
Leenhardt R, Buisson A, Bourreille A, Marteau P, Koulaouzidis A, Li C, et al. Nomenclature and semantic descriptions of ulcerative and inflammatory lesions seen in Crohn’s disease in small bowel capsule endoscopy: An international Delphi consensus statement. United Eur Gastroenterol J. 2020;8(1):99-107.
Na SY, Lim YJ. Capsule endoscopy in inflammatory bowel disease: When? to whom? Diagnostics. 2021;11(12):1-2.
Mow WS, Lo SK, Targan SR, Dubinsky MC, Treyzon L, Abreu-Martin MT, et al. Initial experience with wireless capsule enteroscopy in the diagnosis and management of inflammatory bowel disease. Clin Gastroenterol Hepatol. 2004;2(1):31-40.
Kopylov U, Nemeth A, Koulaouzidis A, Makins R, Wild G, Afif W, et al. Small bowel capsule endoscopy in the management of established Crohn’s disease: Clinical impact, safety, and correlation with inflammatory biomarkers. Inflamm Bowel Dis. 2015;21(1):93-100.
Niv Y. Small-bowel mucosal healing assessment by capsule endoscopy as a predictor of long-term clinical remission in patients with Crohn’s disease: A systematic review and metaanalysis. Eur J Gastroenterol Hepatol. 2017;29(7):844-8.
Yung DE, Har-Noy O, Tham YS, Ben-Horin S, Eliakim R, Koulaouzidis A, et al. Capsule Endoscopy, Magnetic Resonance Enterography, and Small Bowel Ultrasound for Evaluation of Postoperative Recurrence in Crohn’s Disease: Systematic Review and Meta-Analysis. Inflamm Bowel Dis. 2018;24(1):93-100.
Negreanu L, Smarandache G, Mateescu RB. Role of capsule endoscopy Pillcam COLON 2 in patients with known or suspected Crohn’s disease who refused colonoscopy or underwent incomplete colonoscopic exam: A case series. Tech Coloproctol. 2014;18(3):277-83.
Bruining DH, Oliva S, Fleisher MR, Fischer M, Fletcher JG. Panenteric capsule endoscopy versus ileocolonoscopy plus magnetic resonance enterography in Crohn’s disease: A multicentre, prospective study. BMJ Open Gastroenterol. 2020;7(1):1-2.
Chateau T, Peyrin-Biroulet L. Evolving therapeutic goals in Crohn’s disease management. United Eur Gastroenterol J.2020;8(2):133-9.
Lichtenstein GR, Loftus E V., Isaacs KL, Regueiro MD, Gerson LB, Sands BE. ACG Clinical Guideline: Management of Crohn’s Disease in Adults. Am J Gastroenterol. 2018;113(4):481-517.
Fausel RA, Kornbluth A, Dubinsky MC. The First Endoscopy in Suspected Inflammatory Bowel Disease. Gastrointest Endosc Clin N Am. 2016;26(4):593-610.
Magro F, Gionchetti P, Eliakim R, Ardizzone S, Armuzzi A, Barreiro-de Acosta M, et al. Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 1: Definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and ileo-anal pouch disorders. J Crohn’s Colitis. 2017;11(6):649-70.
Shergill AK, Lightdale JR, Bruining DH, Acosta RD, Chandrasekhara V, Chathadi K V, et al. The role of endoscopy in inflammatory bowel disease. Gastrointest Endosc. 2015;81(5):1101-1121.e13.
Kedia S, Das P, Madhusudhan KS, Dattagupta S, Sharma R, Sahni P, et al. Differentiating Crohn’s disease from intestinal tuberculosis. World J Gastroenterol. 2019;25(4):418-32.
Gomollón F, Dignass A, Annese V, Tilg H, Van Assche G, Lindsay JO, et al. 3rd European evidence-based consensus on the diagnosis and management of Crohn’s disease 2016: Part 1: Diagnosis and medical management. J Crohn’s Colitis. 2017;11(1):3-25.
Adamina M, Feakins R, Iacucci M, Spinelli A, Cannatelli R, D’Hoore A, et al. ECCO Topical Review Optimising Reporting in Surgery, Endoscopy, and Histopathology. J Crohn’s Colitis. 2021;15(7):1089-105.
Khanna R, Bouguen G, Feagan BG, D’Haens G, Sandborn WJ, Dubcenco E, et al. A systematic review of measurement of endoscopic disease activity and mucosal healing in Crohn’s disease: Recommendations for clinical trial design. Inflamm Bowel Dis. 2014;20(10):1850-61.
Kishi M, Hirai F, Takatsu N, Hisabe T, Takada Y, Beppu T, et al. A review on the current status and definitions of activity indices in inflammatory bowel disease: how to use indices for precise evaluation. J Gastroenterol. 2022;57(4):246-66.
Khanna R, Ma C, Hogan M, Zou G, Bessissow T, Bressler B, . Standardizing Scoring Conventions for Crohn’s Disease Endoscopy: An International RAND/UCLA Appropriateness Study. Clin Gastroenterol Hepatol. 2023;8-9.
Adler J, Eder SJ, Gebremariam A, Moran CJ, Bass LM, Moses J, et al. Quantification of Mucosal Activity from Colonoscopy Reports via the Simplified Endoscopic Mucosal Assessment for Crohn’s Disease. Inflamm Bowel Dis. 2022;28(10):1537-42.
Rubin DT, Ananthakrishnan AN, Siegel CA, Sauer BG, Long MD. ACG Clinical Guideline: Ulcerative Colitis in Adults. Am J Gastroenterol. 2019;114(3):384-413.
Di Ruscio M, Variola A, Vernia F, Lunardi G, Castelli P, Bocus P, et al. Role of Ulcerative Colitis Endoscopic Index of Severity (UCEIS) versus Mayo Endoscopic Subscore (MES) in Predicting Patients′ Response to Biological Therapy and the Need for Colectomy. Digestion. 2021;102(4):534-45.
Mowat C, Cole A, Windsor A, Ahmad T, Arnott I, Driscoll R, et al. Guidelines for the management of inflammatory bowel disease in adults. Gut. 2011;60(5):571-607.
Harbord M, Eliakim R, Bettenworth D, Karmiris K, Katsanos K, Kopylov U, et al. Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 2: Current management. J Crohn’s Colitis. 2017;11(7):769=84.
Odze R, Antonioli D, Peppercorn M, Goldman H. Effect of topical 5-aminosalicylic acid (5-ASA) therapy on rectal mucosal biopsy morphology in chronic ulcerative colitis. Am J Surg Pathol. 1993;17(9):869-75.
Kim B, Barnett JL, Kleer CG, Appelman HD. Endoscopic and Histological Patchiness in Treated Ulcerative Colitis. Am J Gastroenterol. 1999;94(11):3258-62.
Kato J, Kuriyama M, Hiraoka S, Yamamoto K. Is sigmoidoscopy sufficient for evaluating inflammatory status of ulcerative colitis patients? J Gastroenterol Hepatol. 2011;26(4):683-7.
Colombel JF, Ordás I, Ullman T, Rutgeerts P, Chai A, O’Byrne S, et al. Agreement between Rectosigmoidoscopy and Colonoscopy Analyses of Disease Activity and Healing in Patients with Ulcerative Colitis. Gastroenterology. 2016;150(2):389-395.e3.
Nuñez F P, Mahadevan U, Quera R, Bay C, Ibañez P. Treat-totarget approach in the management of inflammatory Bowel disease. Gastroenterol Hepatol. 2021;44(4):312-9.
Park SB, Kim SJ, Lee J, Lee YJ, Baek DH, Seo GS, et al. Efficacy of sigmoidoscopy for evaluating disease activity in patients with ulcerative colitis. BMC Gastroenterol. 2022;22(1):1-2.
Rubin CE, Haggitt RC, Burmer GC, Brentnall TA, Stevens AC, Levine DS, et al. DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis. Gastroenterology. 1992;103(5):1611-20.
Rutter MD, Riddell RH. Colorectal dysplasia in inflammatory bowel disease: A clinicopathologic perspective. Clin Gastroenterol Hepatol. 2014;12(3):359-67.
Cohen-Mekelburg S, Schneider Y, Gold S, Scherl E, Steinlauf A. Advances in the diagnosis and management of colonic dysplasia in patients with inflammatory bowel disease. Gastroenterol Hepatol. 2017;13(6):357-62.
Bessissow T, Dulai PS, Restellini S, Landry T, Bisschops R, Murad MH, et al. Comparison of endoscopic dysplasia detection techniques in patients with ulcerative colitis: A systematic review and network meta-analysis. Inflamm Bowel Dis. 2018;24(12):2518-26.
Imperatore N, Castiglione F, Testa A, De Palma GD, Caporaso N, Cassese G, et al. Augmented endoscopy for surveillance of colonic inflammatory bowel disease: Systematic review with network meta-analysis. J Crohn’s Colitis. 2019;13(6):714-24.
Iannone A, Ruospo M, Palmer SC, Principi M, Barone M, Di Leo A, et al. Systematic review with network meta-analysis: endoscopic techniques for dysplasia surveillance in inflammatory bowel disease. Aliment Pharmacol Ther. 2019;50(8):858-71.
Resende RH, Ribeiro IB, de Moura DTH, Galetti F, Rocha RS de P, Bernardo WM, et al. Surveillance in inflammatory bowel disease: is chromoendoscopy the only way to go? A systematic review and meta-analysis of randomized clinical trials. Endosc Int Open. 2020;08(05):E578-90.
Rutter M, Bernstein C, Matsumoto T, Kiesslich R, Neurath M. Endoscopic appearance of dysplasia in ulcerative colitis and the role of staining. Endoscopy. 2004;36(12):1109-14.
El Dallal M, Chen Y, Lin Q, Rakowsky S, Sattler L, Foromera J, et al. Meta-Analysis of virtual-based chromoendoscopy compared with dye-spraying chromoendoscopy standard and high-definition white light endoscopy in patients with inflammatory bowel disease at increased risk of colon cancer. Inflamm Bowel Dis. 2020;26(9):1319-29.
Kiesslich R, Fritsch J, Holtmann M, Koehler HH, Stolte M, Kanzler S, et al. Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. Gastroenterology. 2003;124(4):880-8.
Subramanian V, Mannath J, Ragunath K, Hawkey CJ. Metaanalysis: The diagnostic yield of chromoendoscopy for detecting dysplasia in patients with colonic inflammatory bowel disease. Aliment Pharmacol Ther. 2011;33(3):304-12.
Alexandersson B, Hamad Y, Andreasson A, Rubio CA, Ando Y, Tanaka K, et al. High-Definition Chromoendoscopy Superior to High-Definition White-Light Endoscopy in Surveillance of Inflammatory Bowel Diseases in a Randomized Trial. Clin Gastroenterol Hepatol. 2020;18(9):2101-7.
Pellisé M, López-Cerón M, Rodríguez De Miguel C, Jimeno M, Zabalza M, Ricart E, et al. Narrow-band imaging as an alternative to chromoendoscopy for the detection of dysplasia in long-standing inflammatory bowel disease: A prospective, randomized, crossover study. Gastrointest Endosc. 2011;74(4):840-8.
Efthymiou M, Allen PB, Taylor ACF, Desmond P V., Jayasakera C, De Cruz P, et al. Chromoendoscopy versus narrow band imaging for colonic surveillance in inflammatory bowel disease. Inflamm Bowel Dis. 2013;19(10):2132-8.
Bisschops R, Bessissow T, Joseph JA, Baert F, Ferrante M, Ballet V, et al. Chromoendoscopy versus narrow band imaging in UC: A prospective randomised controlled trial. Gut. 2018;67(6):1087-94.
Iacucci M, Kaplan GG, Panaccione R, Akinola O, Lethebe BC, Lowerison M, et al. A randomized trial comparing high definition colonoscopy alone with high definition dye spraying and electronic virtual chromoendoscopy for detection of colonic neoplastic lesions during IBD surveillance colonoscopy. Am J Gastroenterol. 2018;113(2):225-34.
Farraye FA, Odze RD, Eaden J, Itzkowitz SH. AGA Technical Review on the Diagnosis and Management of Colorectal Neoplasia in Inflammatory Bowel Disease. Gastroenterology. 2010;138(2):20141809.
Ooi CJ, Makharia GK, Hilmi I, Gibson PR, Fock KM, Ahuja V, et al. Asia Pacific Consensus Statements on Crohn’s disease. Part 1: Definition, diagnosis, and epidemiology: (Asia Pacific Crohn’s Disease Consensus-Part 1). J Gastroenterol Hepatol. 2016;31(1):45-55.
Leong R, Corte C, Koh C, Wu B, Kariyawasam V, Chetcuti A, et al Clinical practice guidelines for surveillance colonoscopy. Sydney: Cancer Council Australia; 2022.
Sicilia B, Vicente R, Arias L, Echarri A, Zabana Y, Mañosa M, et al. Recommendations of the Spanish Working Group on Crohn’s disease and Ulcerative Colitis (Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa — GETECCU) on dysplasia screening in inflammatory bowel disease patients. Gastroenterol Hepatol. 2021;44(6):435-47.
Selinger CP, Andrews JM, Titman A, Norton I, Jones DB, McDonald C, et al. Long-term Follow-up Reveals Low Incidence of Colorectal Cancer, but Frequent Need for Resection, Among Australian Patients With Inflammatory Bowel Disease. Clin Gastroenterol Hepatol. 2014;12(4):644-50.
Gyde SN, Prior P, Allan RN, Stevens A, Jewell DP, Truelove SC, et al. Colorectal cancer in ulcerative colitis: A cohort study of primary referrals from three centres. Gut. 1988;29(2):206-17.
Gascogne N. Ulcerative colitis and colorectal cancer. Cancer J. 1991;4(1):7-8.
Sugita A, Sachar DB, Bodian C, Ribeiro MB, Aufses AH, Greenstein AJ. Colorectal cancer in ulcerative colitis. Influence of anatomical extent and age at onset on colitis-cancer interval. Gut. 1991;32(2):167-9.
Baars JE, Looman CWN, Steyerberg EW, Beukers R, Tan ACITL, Weusten BLAM, et al. The risk of inflammatory bowel disease-related colorectal carcinoma is limited: Results from a nationwide nested case-control study. Am J Gastroenterol. 2011;106(2):319-28.
Mooiweer E, Van Der Meulen AE, Van Bodegraven AA, Jansen JM, Mahmmod N, Nijsten J, et al. Neoplasia yield and colonoscopic workload of surveillance regimes for colorectal cancer in colitis patients: A retrospective study comparing the performance of the updated AGA and BSG guidelines. Inflamm Bowel Dis. 2013;19(12):2603-10.
Matsuoka H, Ikeuchi H, Uchino M, Bando T, Takesue Y, Nishigami T, et al. Clinicopathological features of ulcerative colitis-associated colorectal cancer pointing to efficiency of surveillance colonoscopy in a large retrospective Japanese cohort. Int J Colorectal Dis. 2013;28(6):829-34.
Lashner BA, Turner BC, Bostwick DG, Frank PH, Hanauer SB. Dysplasia and cancer complicating strictures in ulcerative colitis. Dig Dis Sci. 1990;35(3):349-52.
Rutter MD, Saunders BP, Wilkinson KH, Rumbles S, Schofield G, Kamm MA, et al. Cancer surveillance in longstandinq ulcerative colitis: Endoscopic appearances help predict cancer risk. Gut. 2004;53(12):1813-6.
Boonstra K, Weersma RK, van Erpecum KJ, Rauws EA, Spanier BWM, Poen AC, et al. Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis. Hepatology. 2013;58(6):2045-55.
Lindström L, Lapidus A, Öst Å, Bergquist A. Increased risk of colorectal cancer and dysplasia in patients with Crohn’s colitis and primary sclerosing cholangitis. Dis Colon Rectum. 2011;54(11):1392-7.
Laine L, Kaltenbach T, Barkun A, McQuaid KR, Subramanian V, Soetikno R. SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease. Gastrointest Endosc. 2015;81(3):489-501.e26.
Sanduleanu S, Kaltenbach T, Barkun A, McCabe RP, Velayos F, Picco MF, et al. A roadmap to the implementation of chromoendoscopy in inflammatory bowel disease colonoscopy surveillance practice. Gastrointest Endosc. 2016;83(1):213-22.
Flynn AD, Valentine JF. Chromoendoscopy for dysplasia surveillance in inflammatory bowel disease. Inflamm Bowel Dis. 2018;24(7):1440-52.
Olliver JR, Wild CP, Sahay P, Dexter S, Hardie LJ. Chromoendoscopy with methylene blue and associated DNA damage in Barrett’s oesophagus. Lancet. 2003;362(9381):373-4.
Repici A, Wallace MB, East JE, Sharma P, Ramirez FC, Bruining DH, et al. Efficacy of Per-oral Methylene Blue Formulation for Screening Colonoscopy. Gastroenterology. 2019;156(8):2198-2207.e1.
Kiesslich R, Neurath MF. Surveillance colonoscopy in ulcerative colitis: Magnifying chromoendoscopy in the spotlight. Gut. 2004;53(2):165-7.
Kudo S, Rubio CA, Teixeira CR, Kashida H, Kogure E. Pit pattern in colorectal neoplasia: Endoscopic magnifying view. Endoscopy. 2001;33(4):367-73.
Iacucci M, Hassan C, Gasia MF, Urbanski S, Gui X, Eksteen B, et al. Serrated adenoma prevalence in inflammatory bowel disease surveillance colonoscopy, and characteristics revealed by chromoendoscopy and virtual chromoendoscopy. Can J Gastroenterol Hepatol. 2014;28(11):589-94.
East JE, Toyonaga T, Suzuki N. Endoscopic management of nonpolypoid colorectal lesions in colonic IBD. Gastrointest Endosc Clin N Am. 2014;24(3):435-45.
Krugliak Cleveland N, Huo D, Sadiq F, Sofia MA, Marks J, Cohen RD, et al. Assessment of peri-polyp biopsy specimens of flat mucosa in patients with inflammatory bowel disease. Gastrointest Endosc. 2018;87(5):1304-9.
ten Hove JR, Mooiweer E, Dekker E, van der Meulen-de Jong AE, Offerhaus GJA, Ponsioen CY, et al. Low Rate of Dysplasia Detection in Mucosa Surrounding Dysplastic Lesions in Patients Undergoing Surveillance for Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol. 2017;15(2):222-228.e2.
Lahiff C, Wang LM, Travis SPL, East JE. Diagnostic yield of dysplasia in polyp-adjacent biopsies for patients with inflammatory bowel disease: A cross-sectional study. J Crohn’s Colitis. 2018;12(6):670-6.
Aladrén B, González-Lama Y, García-Alvarado M, Sierra M, Barrio J, Vicente V, et al. Even non-experts identify non-dysplastic lesions in inflammatory bowel disease via chromoendoscopy: results of a screening program in real-life. Endosc Int Open. 2019;07(06):E743-50.
Gasia MF, Ghosh S, Panaccione R, Ferraz JG, Kaplan GG, Leung Y, et al. Targeted Biopsies Identify Larger Proportions of Patients With Colonic Neoplasia Undergoing High-Definition Colonoscopy, Dye Chromoendoscopy, or Electronic Virtual Chromoendoscopy. Clin Gastroenterol Hepatol. 2016;14(5):704-712.e4.
Rutter MD, Saunders BP, Wilkinson KH, Kamm MA, Williams CB, Forbes A. Most dysplasia in ulcerative colitis is visible at colonoscopy. Gastrointest Endosc. 2004;60(3):334-9.
Rubin DT, Rothe JA, Hetzel JT, Cohen RD, Hanauer SB. Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis? Gastrointest Endosc. 2007;65(7):998-1004.
Mahmoud R, Shah SC, Torres J, Castaneda D, Glass J, Elman J, et al. Association Between Indefinite Dysplasia and Advanced Neoplasia in Patients With Inflammatory Bowel Diseases Undergoing Surveillance. Clin Gastroenterol Hepatol. 2020;18(7):1518-1527.e3.
Sugimoto S, Naganuma M, Iwao Y, Matsuoka K, Shimoda M, Mikami S, et al. Endoscopic morphologic features of ulcerative colitis–associated dysplasia classified according to the SCENIC consensus statement. Gastrointest Endosc. 2017;85(3):639-646.e2.
Bisschops R, East JE, Hassan C, Hazewinkel Y, Kamiński MF, Neumann H, et al. Advanced imaging for detection and differentiation of colorectal neoplasia: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - Update 2019. Endoscopy. 2019;51(12):1155-79.
Wanders LK, Dekker E, Pullens B, Bassett P, Travis SPL, East JE. Cancer risk after resection of polypoid dysplasia in patients with longstanding ulcerative colitis: A meta-analysis. Clin Gastroenterol Hepatol. 2014;12(5):756-64.
Kabir M, Fofaria R, Arebi N, Bassett P, Tozer PJ, Hart AL, et al. Systematic review with meta-analysis: IBD-associated colonic dysplasia prognosis in the videoendoscopic era (1990 to present). Aliment Pharmacol Ther. 2020;52(1):5-19.
Deepak P, Hanson GJ, Fletcher JG, Tremaine WJ, Pardi DS, Kisiel JB, et al. Incremental diagnostic yield of chromoendoscopy and outcomes in inflammatory bowel disease patients with a history of colorectal dysplasia on white-light endoscopy. Gastrointest Endosc. 2016;83(5):1005-12.
Iacucci M, McQuaid K, Gui XS, Iwao Y, Lethebe BC, Lowerison M, et al. A multimodal (FACILE) classification for optical diagnosis of inflammatory bowel disease associated neoplasia. Endoscopy. 2019;51(2):133-41.
Gulati S, Emmanuel A, Burt M, Dubois P, Hayee B, Haji A. Outcomes of Endoscopic Resections of Large Laterally Spreading Colorectal Lesions in Inflammatory Bowel Disease: A Single United Kingdom Center Experience. Inflamm Bowel Dis. 2018;24(6):1196-203.
Matsumoto K, Oka S, Tanaka S, Tanaka H, Boda K, Yamashita K, et al. Long-Term Outcomes after Endoscopic Submucosal Dissection for Ulcerative Colitis-Associated Dysplasia. Digestion. 2021;102(2):205-15.
Ten Hove JR, Mooiweer E, Van Der Meulen De Jong AE, Dekker E, Ponsioen CY, Siersema PD, et al. Clinical implications of low grade dysplasia found during inflammatory bowel disease surveillance: A retrospective study comparing chromoendoscopy and white-light endoscopy. Endoscopy. 2017;49(2):161-8.
De Cruz P, Kamm MA, Hamilton AL, Ritchie KJ, Krejany EO, Gorelik A, et al. Crohn’s disease management after intestinal resection: A randomised trial. Lancet. 2015;385(9976):1406-17.
Murthy SK, Feuerstein JD, Nguyen GC, Velayos FS. AGA Clinical Practice Update on Endoscopic Surveillance and Management
of Colorectal Dysplasia in Inflammatory Bowel Diseases: Expert Review. Gastroenterology. 2021;161(3):1043-1051.e4.
Marteau P, Laharie D, Colombel JF, Martin L, Coevoet H, Allez M, et al. Interobserver variation study of the rutgeerts score to assess endoscopic recurrence after surgery for Crohn’s disease. J Crohn’s Colitis. 2016;10(9):1001-5.
Domènech E, López-Sanromán A, Nos P, Vera M, Chaparro M, Esteve M, et al. Recommendations of the Spanish Working Group on Crohn’s Disease and Ulcerative Colitis (GETECCU) on the monitoring, prevention and treatment of post-operative recurrence in Crohn’s disease. Gastroenterol Hepatol. 2017;40(7):472-83.
Hart L, Bessissow T. Endoscopic scoring systems for the evaluation and monitoring of disease activity in Crohn’s disease. Best Pract Res Clin Gastroenterol. 2019;38-39:31327405.
Rivière P, Vermeire S, Irles-Depe M, Van Assche G, Rutgeerts P, de Buck van Overstraeten A, et al. No Change in Determining Crohn’s Disease Recurrence or Need for Endoscopic or Surgical Intervention With Modification of the Rutgeerts’ Scoring System. Clin Gastroenterol Hepatol. 2019;17(8):1643-5.
Oberc A, Shen B. Preparation of Endoscopic Therapy for Inflammatory Bowel Diseases. Interv Inflamm Bowel Dis Endosc Manag Treat Complicat. 2018;137-40.
Van Assche G, Vermeire S, Rutgeerts P. Management of acute severe ulcerative colitis. Gut. 2011;60(1):130-3.
Travis SPL, Stange EF, Lémann M, Øresland T, Bemelman WA, Chowers Y, et al. European evidence-based Consensus on the management of ulcerative colitis: Current management. J Crohn’s Colitis. 2008;2(1):24-62.
Wu KL, Rayner CK, Chuah SK, Chiu KW, Lu CC, Chiu YC. Impact of low-residue diet on bowel preparation for colonoscopy.Dis Colon Rectum. 2011;54(1):107-12.
Hassan C, East J, Radaelli F, Spada C, Benamouzig R, Bisschops R, et al. Bowel preparation for colonoscopy: European society of gastrointestinal endoscopy (esge) guideline-update 2019. Endoscopy. 2019;51(8):775-94.
Cerna-Cardona J, Peláez-Luna M, Casillas-Guzmán GB, Sánchez-Chávez X, Casanova-Lara AI, Espino-Cortés H, et al. Guía de endoscopia en enfermedad inflamatoria intestinal. Rev Endosc. 2022;33(1):22-44.
Rejchrt S, Bureš J, Široký M, Kopáčová M, Slezák L, Langr F. A prospective, observational study of colonic mucosal abnormalities associated with orally administered sodium phosphate for colon cleansing before colonoscopy. Gastrointest Endosc. 2004;59(6):651-4.
Lawrance IC, Willert RP, Murray K. Bowel cleansing for colonoscopy: Prospective randomized assessment of efficacy and of induced mucosal abnormality with three preparation agents. Endoscopy. 2011;43(5):412-8.
Gurudu SR. Morning-only polyethylene glycol preparation for afternoon colonoscopy is superior to traditional eveningbefore preparation. Evid Based Med. 2011;16(3):87-8.
Park SS, Sinn DH, Kim YH, Lim YJ, Sun Y, Lee JH, et al. Efficacy and tolerability of split-dose magnesium citrate: Lowvolume (2 liters) polyethylene glycol vs. single-or split-dose polyethylene glycol bowel preparation for morning colonoscopy. Am J Gastroenterol. 2010;105(6):1319-26.
Gurudu SR, Ratuapli S, Heigh R, Dibaise J, Leighton J, Crowell M. Quality of bowel cleansing for afternoon colonoscopy is influenced by time of administration. Am J Gastroenterol. 2010;105(11):2318-22.
Song HJ, Moon JS, Do JH, Cha IH, Yang CH, Choi MG, et al. Guidelines for bowel preparation before video capsule endoscopy. Clin Endosc. 2013;46(2):147-54.
Kantianis A, Karagiannis S, Liatsos C, Galanis P, Psilopoulos D, Tenta R, et al. Comparison of two schemes of small bowel preparation for capsule endoscopy with polyethylene glycol: A prospective, randomized single-blind study. Eur J Gastroenterol Hepatol. 2009;21(10):1140-4.
Takano R, Osawa S, Uotani T, Tani S, Ishida N, Tamura S, et al. Evaluating mucosal healing using colon capsule endoscopy predicts outcome in patients with ulcerative colitis in clinical remission. World J Clin Cases. 2018;6(15):952-60.
Okabayashi S, Kobayashi T, Nakano M, Toyonaga T, Ozaki R, Tablante MC, et al. A Simple 1-Day Colon capsule endoscopy procedure demonstrated to be a highly acceptable monitoring tool for ulcerative colitis. Inflamm Bowel Dis. 2018;24(11):2404-12.
De Sousa Magalhães R, Boal Carvalho P, Rosa B, Moreira MJ, Cotter J. The Prediction of Inadequate Colon Capsule Cleansing: A Cohort Selection Guided by CC-CLEAR. GE Port J Gastroenterol. 2021;29(5):311-321.
Teshima CW, May G. Small bowel enteroscopy. Can J Gastroenterol. 2012;26(5):269-75.
Kedia S, Sharma R, Makharia G, Ahuja V, Desai D, Kandasamy D, et al. Indian guidelines on imaging of the small intestine in Crohn’s disease: A joint Indian Society of Gastroenterology and Indian Radiology and Imaging Association consensus statement. Indian J Radiol Imaging. 2019;29(2):111-32.
Shen B, Kochhar G, Navaneethan U, Liu X, Farraye FA, Gonzalez-Lama Y, et al. Role of interventional inflammatory bowel disease in the era of biologic therapy: a position statement from the Global Interventional IBD Group. Gastrointest Endosc. 2019;89(2):215-37.
Sleiman J, Chirra P, Gandhi NS, Baker ME, Lu C, Gordon IO, et al. Crohn’s disease related strictures in cross-sectional imaging: More than meets the eye? United Eur Gastroenterol J.2022;10(10):1167-78.
Lightner AL, Vogel JD, Carmichael JC, Keller DS, Shah SA, Mahadevan U, et al. The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Surgical Management of Crohn’s Disease. Dis Colon Rectum. 2020;63(8):1028-52.
Lan N, Shen B. Endoscopic Stricturotomy Versus Balloon Dilation in the Treatment of Anastomotic Strictures in Crohn’s Disease. Inflamm Bowel Dis. 2018;24(4):897-907.
Loras C, Mañosa M, Andújar X, Sánchiz V, Martí-Gallostra M, Zabana Y, et al. Position Statement. Recommendations of the Spanish Group on Crohn’s Disease and Ulcerative Colitis (GETECCU) on the treatment of strictures in Crohn’s disease. Gastroenterol Hepatol. 2022;45(4):315-34.
Bemelman WA, Warusavitarne J, Sampietro GM, Serclova Z, Zmora O, Luglio G, et al. ECCO-ESCP consensus on surgery for Crohn’s disease. J Crohn’s Colitis. 2018;12(1):1-16.
Ismail MS, Charabaty A. Management of Crohn’s stricture: medical, endoscopic and surgical therapies. Frontline Gastroenterol. 2022;13(6):524-530.
Fousekis FS, Mitselos IV, Tepelenis K, et al. Medical, Endoscopic and Surgical Management of Stricturing Crohn's Disease: Current Clinical Practice. J Clin Med. 2022;11(9):2366
Terheggen G, Lanyl B, Schanz S, Hoffmann RM, Böhm SK, Leifeld L, et al. Safety, feasibility, and tolerability of ileocolonoscopy in inflammatory bowel disease. Endoscopy. 2008;40(8):656-63.
Hong SM, Baek DH. A Review of Colonoscopy in Intestinal Diseases. Diagnostics. 2023;13(7):37046479.
Shen B. Principles, Preparation, Indications, Precaution, and Damage Control of Endoscopic Therapy in Inflammatory Bowel Disease. Gastrointest Endosc Clin N Am. 2022;32(4):597-614.
Almario C V, Shergill J, Oh J. Measuring and Improving Quality of Colonoscopy for Colorectal Cancer Screening. Tech Innov Gastrointest Endosc. 2022;24(3):269-83.
Keswani RN, Crockett SD, Calderwood AH. AGA Clinical Practice Update on Strategies to Improve Quality of Screening and Surveillance Colonoscopy: Expert Review. Gastroenterology. 2021;161(2):701-11.
Manes G, Imbesi V, Ardizzone S, Cassinotti A, Bosani M, Massari A, et al. Appropriateness and diagnostic yield of colonoscopy in the management of patients with ulcerative colitis: A prospective study in an open access endoscopy service. Inflamm Bowel Dis. 2008;14(8):1133-8.
Frazzoni L, La Marca M, Radaelli F, Spada C, Laterza L, Zagari RM, et al. Systematic review with meta-analysis: the appropriateness of colonoscopy increases the probability of relevant findings and cancer while reducing unnecessary exams. Aliment Pharmacol Ther. 2021;53(1):22-32.
Rex DK, Schoenfeld PS, Cohen J, Pike IM, Adler DG, Fennerty MB, et al. Quality indicators for colonoscopy. Am J Gastroenterol. 2015;110(1):72-90.
Dekker E, Nass KJ, Iacucci M, Murino A, Sabino J, Bugajski M, et al. Performance measures for colonoscopy in inflammatory bowel disease patients: European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative. Endoscopy. 2022;54(9):904-15.
Dekker E, Houwen BBSL, Puig I, Bustamante-Balén M, Coron E, Dobru DE, . Curriculum for optical diagnosis training in Europe: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement. Endoscopy. 2020;52(10):899-923. Erratum in: Endoscopy. 2020;52(10):C10.
Dejaco C, Oesterreicher C, Angelberger S, Püspök A, Birner P, Poetzi R, et al. Diagnosing colitis: A prospective study on essential parameters for reaching a diagnosis. Endoscopy. 2003;35(12):1004-8.
Kaminski MF, Thomas-Gibson S, Bugajski M, Bretthauer M, Rees CJ, Dekker E, et al. Performance measures for lower gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy (ESGE) quality improvement initiative. United Eur Gastroenterol J. 2017;5(3):309-34.
Peyrin-Biroulet L, Panés J, Sandborn WJ, Vermeire S, Danese S, Feagan BG, et al. Defining Disease Severity in Inflammatory Bowel Diseases: Current and Future Directions. Clin Gastroenterol Hepatol. 2016;14(3):348-354.e17.
Yang JY, Lund JL, Pate V, Kappelman MD. Utilization of Colonoscopy Following Treatment Initiation in U.S. Commercially Insured Patients With Inflammatory Bowel Disease, 2013-2019. Inflamm Bowel Dis. 2023;29(5):735-43.
Pouw RE, Bisschops R, Gecse KB, De Hertogh G, Iacucci M, Rutter M, et al. Endoscopic tissue sampling - Part 2: Lower gastrointestinal tractEuropean Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy. 2021;53(12):1261-73.
Yang JY, Lund JL, Funk MJ, Hudgens MG, Lewis JD, Kappelman MD. Utilization of Treat-to-Target Monitoring Colonoscopy After Treatment Initiation in the US-Based Study of a Prospective Adult Research Cohort With Inflammatory Bowel Disease. Am J Gastroenterol. 2023;118(9):1638-1647.
Storm AC, Fishman DS, Buxbaum JL, Coelho-Prabhu N, Al-Haddad MA, Amateau SK, et al. American Society for Gastrointestinal Endoscopy guideline on informed consent for GI endoscopic procedures. Gastrointest Endosc. 2022;95(2):207-215.e2.
May FP, Shaukat A. State of the Science on Quality Indicators for Colonoscopy and How to Achieve Them. Am J Gastroenterol. 2020;115(8):1183-90.
Segarajasingam DS, Pawlik J, Forbes GM. Informed consent in direct access colonoscopy. J Gastroenterol Hepatol. 2007;22(12):2081-5.
Gerstenberger PD, Plumeri PA. Malpractice claims in gastrointestinal endoscopy: analysis of an insurance industry data base. Gastrointest Endosc. 1993;39(2):132-8.
Hernandez L V. Malpractice claims for endoscopy. World J Gastrointest Endosc. 2013;5(4):169.
Rex DK. Key quality indicators in colonoscopy. Gastroenterol Rep. 2023;11:36911141.
Thrumurthy SG, Thrumurthy SSD, Gilbert CE, Ross P, Haji A. Colorectal adenocarcinoma: Risks, prevention and diagnosis. BMJ. 2016;354:27418368.
Fiorino G, Lytras T, Younge L, Fidalgo C, Coenen S, Chaparro M, et al. Quality of care standards in inflammatory bowel diseases: A European Crohn’s and colitis organisation [ECCO] position paper. J Crohn’s Colitis. 2020;14(8):1037-48.
Buisson A, Chevaux JB, Hudziak H, Bresler L, Bigard MA, Peyrin-Biroulet L. Colonoscopic perforations in inflammatory bowel disease: A retrospective study in a French referral centre. Dig Liver Dis. 2013;45(7):569-72.
Patil DT, Odze RD. Backwash Is Hogwash: The Clinical Significance of Ileitis in Ulcerative Colitis. Am J Gastroenterol. 2017;112(8):1211-4.
Hamilton MJ, Makrauer FM, Golden K, Wang H, Friedman S, Burakoff RB, et al. Prospective Evaluation of Terminal Ileitis in a Surveillance Population of Patients with Ulcerative Colitis. Inflamm Bowel Dis. 2016;22(10):2448-55.
Neilson LJ, Bevan R, Panter S, Thomas-Gibson S, Rees CJ. Terminal ileal intubation and biopsy in routine colonoscopy practice. Expert Rev Gastroenterol Hepatol. 2015;9(5):567-74.
Kundrotas LW, Clement DJ, Kubik CM, Robinson AB, Wolfe PA. A prospective evaluation of successful terminal ileum intubation during routine colonoscopy. Gastrointest Endosc. 1994;40(5):544-6.
Marques S, Bispo M, Pimentel-Nunes P, Chagas C, DInis-Ribeiro M. Image Documentation in Gastrointestinal Endoscopy: Review of Recommendations. GE Port J Gastroenterol. 2017;24(6):269-74.
Aabakken L, Barkun AN, Cotton PB, Fedorov E, Fujino MA, Ivanova E, et al. Standardized endoscopic reporting. J Gastroenterol Hepatol. 2014;29(2):234-40.
Hart L, Chavannes M, Lakatos PL, Afif W, Bitton A, Bressler B, et al. Do You See What I See? An Assessment of Endoscopic Lesions Recognition and Description by Gastroenterology Trainees and Staff Physicians. J Can Assoc Gastroenterol. 2020;3(5):216-21.
Sturm A, Maaser C, Calabrese E, Annese V, Fiorino G, Kucharzik T, et al. Ecco-esgar guideline for diagnostic assessment in ibd part 2: Ibd scores and general principles and technical aspects. J Crohn’s Colitis. 2019;13(3):273-284E.
Tang RSY, Lee JWJ, Chang LC, Ong DEH, Chiu HM, Matsuda T, et al. Two vs One Forward View Examination of Right Colon on
Adenoma Detection: An International Multicenter Randomized Trial. Clin Gastroenterol Hepatol. 2022;20(2):372-380.e2.
Desai M, Bilal M, Hamade N, Gorrepati VS, Thoguluva Chandrasekar V, Jegadeesan R, et al. Increasing adenoma detection rates in the right side of the colon comparing retroflexion with a second forward view: a systematic review. Gastrointest Endosc. 2019;89(3):453-459.e3.
Crockett SD, Nagtegaal ID. Terminology, Molecular Features, Epidemiology, and Management of Serrated Colorectal Neoplasia. Gastroenterology. 2019;157(4):949-966.e4.
Hewett DG, Rex DK. Miss rate of right-sided colon examination during colonoscopy defined by retroflexion: An observational study. Gastrointest Endosc. 2011;74(2):246-52.
Zhao S, Yang X, Wang S, Meng Q, Wang R, Bo L, et al. Impact of 9-Minute Withdrawal Time on the Adenoma Detection Rate: A Multicenter Randomized Controlled Trial. Clin Gastroenterol Hepatol. 2022;20(2):e168-81.
Aziz M, Haghbin H, Gangwani MK, Nawras M, Nawras Y, Dahiya DS, et al. 9-Minute Withdrawal Time Improves Adenoma Detection Rate Compared With 6-Minute Withdrawal Time During Colonoscopy. J Clin Gastroenterol. 2023;8-9.
Zhao S, Song Y, Wang S, Wang R, Feng Z, Gong A, et al. Reduced Adenoma Miss Rate With 9-Minute vs 6-Minute Withdrawal Times for Screening Colonoscopy: A Multicenter Randomized Tandem Trial. Am J Gastroenterol. 2023;118(5):802-11.
Butterly LF. Withdrawal Time: Is Nine the New Six? Clin Gastroenterol Hepatol. 2022;20(2):e22-4.
Clarke K, Kang M, Gorrepati VS, Stine JG, Tinsley A, Williams E, et al. Dysplasia detection is similar between chromoendoscopy and high-definition white-light colonoscopy in inflammatory bowel disease patients: a US-matched casecontrol study. Int J Colorectal Dis. 2020;35(12):2301-7.
Zilli A, Capogreco A, Furfaro F, Allocca M, Roda G, Loy L, et al. Improving quality of care in endoscopy of inflammatory bowel disease: can we do better? Expert Rev Gastroenterol Hepatol. 2020;14(9):819-28.
Rutter MD, Beintaris I, Valori R, Chiu HM, Corley DA, Cuatrecasas M, et al. World Endoscopy Organization Consensus
Statements on Post-Colonoscopy and Post-Imaging Colorectal Cancer. Gastroenterology. 2018;155(3):909-925.e3.
Corley DA, Jensen CD, Marks AR, Zhao WK, Lee JK, Doubeni CA, et al. Adenoma Detection Rate and Risk of Colorectal Cancer and Death. N Engl J Med. 2014;370(14):1298-306.
Schottinger JE, Jensen CD, Ghai NR, Chubak J, Lee JK, Kamineni A, et al. Association of Physician Adenoma Detection Rates with Postcolonoscopy Colorectal Cancer. JAMA. 2022;327(21):2114-22.
Wintjens DSJ, Bogie RMM, van den Heuvel TRA, le Clercq CMC, Oostenbrug LE, Romberg-Camps MJL, et al. Incidence and classification of postcolonoscopy colorectal cancers in inflammatory bowel disease: A Dutch population-based cohort study. J Crohn’s Colitis. 2018;12(7):777-83.
Sanduleanu S, Rutter MD. Interval colorectal cancers in inflammatory bowel disease: The grim statistics and true stories. Gastrointest Endosc Clin N Am. 2014;24(3):337-48.
Jewel Samadder N, Valentine JF, Guthery S, Singh H, Bernstein CN, Wan Y, et al. Colorectal Cancer in Inflammatory Bowel Diseases: A Population-Based Study in Utah. Dig Dis Sci. 2017;62(8):2126-32.
Gordon H, Biancone L, Fiorino G, Katsanos KH, Kopylov U, Al Sulais E, et al. ECCO Guidelines on Inflammatory Bowel Disease and Malignancies. J Crohn’s Colitis. 2023;17(6):827-54.
Paulina Núñez F, Cleveland NK, Quera R, Rubin DT. Evolving role of endoscopy in inflammatory bowel disease: Going beyond diagnosis. World J Gastroenterol. 2021;27(20):2521-30.
Jess T, Rungoe C, Peyrin-Biroulet L. Risk of Colorectal Cancer in Patients With Ulcerative Colitis: A Meta-analysis of Population-Based Cohort Studies. Clin Gastroenterol Hepatol. 2012;10(6):639-45.
Bernstein CN, Blanchard JF, Kliewer E, Wajda A. Cancer risk in patients with inflammatory bowel disease: A populationbased study. Cancer. 2001;91(4):854-62.
Jess T, Gamborg M, Matzen P, Munkholm P, Sørensen TIA. Increased risk of intestinal cancer in Crohn’s disease: A metaanalysis of population-based cohort studies. Am J Gastroenterol. 2005;100(12):2724-9.
Mooiweer E, Van Der Meulen-De Jong AE, Ponsioen CY, Fidder HH, Siersema PD, Dekker E, et al. Chromoendoscopy for surveillance in inflammatory bowel disease does not increase neoplasia detection compared with conventional colonoscopy with random biopsies: Results from a large retrospective study. Am J Gastroenterol. 2015;110(7):1014-21.
Carballal S, Maisterra S, López-Serrano A, Gimeno-García AZ, Vera MI, Marín-Garbriel JC, et al. Real-life chromoendoscopy for neoplasia detection and characterisation in long-standing IBD. Gut. 2018;67(1):70-8.
Al Bakir I, Kabir M, Yalchin M, Hart A. Optimising inflammatory bowel disease surveillance and dysplasia management—Where do we stand? United Eur Gastroenterol J.2022;10(10):1054-62.
Friedman S, Cheifetz AS, Farraye FA, Banks PA, Makrauer FL, Burakoff R, et al. Factors that affect adherence to surveillance colonoscopy in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2013;19(3):534-9.
McLachlan SA, Clements A, Austoker J. Patients’ experiences and reported barriers to colonoscopy in the screening context-A systematic review of the literature. Patient Educ Couns. 2012;86(2):137-46.
Denters MJ, Schreuder M, Depla ACTM, Mallant-Hent RC, Van Kouwen MCA, Deutekom M, et al. Patients’ perception of colonoscopy: Patients with inflammatory bowel disease and irritable bowel syndrome experience the largest burden. Eur J Gastroenterol Hepatol. 2013;25(8):964-72.
Buisson A, Gonzalez F, Poullenot F, Nancey S, Sollellis E, Fumery M, et al. Comparative Acceptability and Perceived Clinical Utility of Monitoring Tools: A Nationwide Survey of Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis. 2017;23(8):1425-33.
Steenholdt C, Jensen JT, Brynskov J, Møller AM, Limschou AC, Konge L, et al. Patient Satisfaction of Propofol Versus Midazolam and Fentanyl Sedation During Colonoscopy in Inflammatory Bowel Disease. Clin Gastroenterol Hepatol. 2022;20(3):559-568.e5.
Bernstein CN, Shanahan F, Anton PA, Weinstein WM. Patchiness of mucosal inflammation in treated ulcerative colitis: A prospective study. Gastrointest Endosc. 1995;42(3):232-7.
Bousvaros A, Morley-Fletcher A, Pensabene L, Cucchiara S. Research and clinical challenges in paediatric inflammatory bowel disease. Dig Liver Dis. 2008;40(1):32-8.
Lengeling RW, Mitros FA, Brennan JA, Schulze KS. Ulcerative ileitis encountered at ileo-colonoscopy: Likely role of nonsteroidal agents. Clin Gastroenterol Hepatol. 2003;1(3):160-9.
Early DS, Lightdale JR, Vargo JJ, Acosta RD, Chandrasekhara V, Chathadi K V, et al. Guidelines for sedation and anesthesia in GI endoscopy. Gastrointest Endosc. 2018;87(2):327=37.
Saltzman JR, Cash BD, Pasha SF, Early DS, Raman Muthusamy V, Khashab MA, et al. Bowel preparation before colonoscopy. Gastrointest Endosc. 2015;81(4):781-94.
Kastenberg D, Bertiger G, Brogadir S. Bowel preparation quality scales for colonoscopy. World J Gastroenterol. 2018;24(26):2833-43.
Marshall JK. Reporting ileocolonoscopy in inflammatory bowel disease. Can J Gastroenterol. 2006;20(6):399-400.
Devlin SM, Melmed GY, Irving PM, Rubin DT, Kornbluth A, Kozuch PL, et al. Recommendations for quality colonoscopy reporting for patients with inflammatory bowel disease: Results from a RAND appropriateness panel. Inflamm Bowel Dis. 2016;22(6):1418-24.
Byeon JS, Yang SK, Myung SJ, Pyo S Il, Park HJ, Kim YM, et al. Clinical course of distal ulcerative colitis in relation to appendiceal orifice inflammation status. Inflamm Bowel Dis. 2005;11(4):366-71.
Tang SJ, Wu R. Ilececum: A Comprehensive Review. Can J Gastroenterol Hepatol. 2019;1451835..
Durak MB, Simsek C, İnan B, Yuksel I. Ileocecal valve that cannot be intubated in Crohn’s disease: is this a sign of poor prognosis? Int J Colorectal Dis. 2023;38(1):1-2.
Iacopini G, Frontespezi S, Vitale MA, Villotti G, Bella A, D’Alba L, et al. Routine ileoscopy at colonoscopy: A prospective evaluation of learning curve and skill-keeping line. Gastrointest Endosc. 2006;63(2):250-6.
Bhasin DK, Goenka MK, Dhavan S, Dass K, Singh K. Diagnostic value of ileoscopy: A report from India. J Clin Gastroenterol. 2000;31(2):144-6.
Velidedeoʇlu M, Arikan AE, Zengin AK. Diagnostic value of terminal ileum biopsies in patients with abnormal terminal ileum mucosal appearance. Turkish J Surg. 2015;31(3):152-6.
Lee JM, Lee KM. Endoscopic diagnosis and differentiation of inflammatory bowel disease. Clin Endosc. 2016;49(4):370-5.
The Paris endoscopic classification of superficial neoplastic lesions: Esophagus, stomach, and colon - November 30 to December 1, 2002. Gastrointest Endosc. 2003;58(6 SUPPL.):14652541.
Waye JD. What Constitutes A Total Colonoscopy? Am J Gastroenterol. 1999;94(6):1429-30.
Grobe JL, Kozarek RA, Sanowski RA. Colonoscopic Retroflexion in the Evaluation of Rectal Disease. Am J Gastroenterol. 1982;77(11):856-8.
Quallick MR, Brown WR. Rectal perforation during colonoscopic retroflexion: a large, prospective experience in an academic center. Gastrointest Endosc. 2009;69(4):960-3.
Téllez-Ávila F, Barahona-Garrido J, García-Osogobio S, López-Arce G, Camacho-Escobedo J, Saúl A, et al. Diagnostic yield and therapeutic impact of rectal retroflexion: A prospective, single-blind study conducted in three centers. Clin Endosc. 2014;47(1):79-83.
Mattar WE, Kumar AS, Olden KW. Perspective on routine rectal retroflexion during screening colonoscopy;A survey of American gastroenterologists. J Gastrointest Liver Dis. 2011;20(1):102-3.
Ardalan ZS, Sparrow MP. A Personalized Approach to Managing Patients With an Ileal Pouch-Anal Anastomosis. Front Med. 2020;6:1-2.
Armstrong D, Barkun A, Bridges R, Carter R, De Gara C, Dubé C, et al. Canadian association of gastroenterology consensus guidelines on safety and quality indicators in endoscopy. Can J Gastroenterol. 2012;26(1):17-31.
O’Connor M, Bager P, Duncan J, Gaarenstroom J, Younge L, Détré P, et al. N-ECCO Consensus statements on the European nursing roles in caring for patients with Crohn’s disease or ulcerative colitis. J Crohn’s Colitis. 2013;7(9):744-64.
Amo L, González-Lama Y, Suárez C, Blázquez I, Matallana V, Calvo M, et al. Impacto de la incorporación de la enfermera a una unidad de enfermedad inflamatoria intestinal. Gastroenterol Hepatol. 2016;39(5):318-23.
Napolitano D, Schiavoni E, Scaldaferri F. Nurse Practitioners in Inflammatory Bowel Disease: The Emerging Role of the IBD Care Manager. J Gastrointest Liver Dis. 2022;31(4):375-7.
Simian D, Flores L, Quera R, Ibáñez P, Figueroa C, Lubascher J, et al. The Role of an Inflammatory Bowel Disease Nurse in the Follow-Up of Patients from a Latin American Inflammatory Bowel Disease Program. Gastroenterol Nurs. 2020;43(1):E16-23.
Fefferman DS, Farrell RJ. Endoscopy in inflammatory bowel disease: Indications, surveillance, and use in clinical practice. Clin Gastroenterol Hepatol. 2005;3(1):11-24.
Pera A, Bellando P, Caldera D, Ponti V, Astegiano M, Barletti C, et al. Colonoscopy in inflammatory bowel disease. Diagnostic accuracy and proposal of an endoscopic score. Gastroenterology. 1987;92(1):181-5.
Baron JH, Connell AM, Lennard-Jones JE. Variation Between Observers in Describing Mucosal Appearances in Proctocolitis. Br Med J. 1964;1(5375):89-92.
de Dombal FT, Watts JM, Watkinson G, Goligher JC. Local complications of ulcerative colitis. Stricture, pseudopolyps and cancer of the colon and rectum. Am J Proctol. 1967;18(3):198-201.
Shivashankar R, Lichtenstein GR. Mimics of inflammatory bowel disease. Inflamm Bowel Dis. 2018;24(11):2315-21.
Woodman I, Schofield JB, Haboubi N. The histopathological mimics of inflammatory bowel disease: a critical appraisal. Tech Coloproctol. 2015;19(12):717-27.
Merino-Gallego E, Gallardo-Sánchez F, Gallego-Rojo FJ. Intestinal tuberculosis and Crohn’s disease: The importance and difficulty of a differential diagnosis. Rev Esp Enfermedades Dig. 2018;110(10):650-6.
Ranzani OT, Pescarini JM, Martinez L, Garcia-Basteiro AL. Increasing tuberculosis burden in Latin America: An alarming trend for global control efforts. BMJ Glob Heal. 2021;6(3):33762254.
Limsrivilai J, Shreiner AB, Pongpaibul A, Laohapand C, Boonanuwat R, Pausawasdi N, et al. Meta-Analytic Bayesian Model for Differentiating Intestinal Tuberculosis from Crohn’s Disease. Am J Gastroenterol. 2017;112(3):415-27.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Viviana Parra-Izquierdo, Fabio Leonel Gil-Parada, Fabian Juliao-Baños, Carolina Pavez-Ovalle, William Otero-Regino, Juan Sebastian Frías-Ordoñez, Asadur Tchekmedyian, Juan Eloy Paredes Mendez, Rodrigo Dorelo, Kenneth Ernest-Suarez, Marcos Leites Madera, María Teresa Galiano, Ximena Pazos, María Luisa Jara-Alaba, Carla María Dias de Oliveira, Keyla Villa Ovalles, Rodrigo Quera, María Carolina Miranda, Lázaro Antonio Arango Molano, Fabian Eduardo Puentes Manosalva, Cyrla Zaltman, Cristian Florez-Sarmiento, Cristina Flores, David Andrade Zamora, Fernando Fluxa, Guillermo Veitia
This work is licensed under a Creative Commons Attribution 4.0 International License.
Revista de Gastroenterología del Perú by Sociedad Peruana de Gastroenterología del Perú is licensed under a Licencia Creative Commons Atribución 4.0 Internacional..
Aquellos autores/as que tengan publicaciones con esta revista, aceptan los términos siguientes:
- Los autores/as conservarán sus derechos de autor y garantizarán a la revista el derecho de primera publicación de su obra, el cuál estará simultáneamente sujeto a la Licencia de reconocimiento de Creative Commons que permite a terceros compartir la obra siempre que se indique su autor y su primera publicación esta revista.
- Los autores/as podrán adoptar otros acuerdos de licencia no exclusiva de distribución de la versión de la obra publicada (p. ej.: depositarla en un archivo telemático institucional o publicarla en un volumen monográfico) siempre que se indique la publicación inicial en esta revista.
- Se permite y recomienda a los autores/as difundir su obra a través de Internet (p. ej.: en archivos telemáticos institucionales o en su página web) antes y durante el proceso de envío, lo cual puede producir intercambios interesantes y aumentar las citas de la obra publicada. (Véase El efecto del acceso abierto).
2022 